Germany-based MorphoSys AG says it is buying U.S. rival Constellation Pharmaceuticals Inc. in a deal valuing the biotech company at $1.7 billion
Related posts
-
Loop-the-Loop: NASCAR restarts its engines for downtown street race
Stock cars on Michigan Avenue? It’s got to be NASCAR returning to Chicago with free admission... -
Conflicting reports of injuries after malfunction halts Wheaton fireworks display
Wheaton’s annual Independence Day fireworks display came to an abrupt and unexpected halt Wednesday night when... -
Daily Herald opinion: On Independence Day, we celebrate our nation’s birth and recommit to its future
Editor's Note: The editorial below is an updated version of one first published on July 4,...